Serotonin, leptin and the central control of bone remodeling

被引:0
作者
Clifford J. Rosen
机构
[1] Maine Medical Center Research Institute,
来源
Nature Reviews Rheumatology | 2009年 / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Researchers have identified a new molecular pathway for the regulation of bone and energy metabolism that challenges the conventional view of the role of leptin in bone turnover.
引用
收藏
页码:657 / 658
页数:1
相关论文
共 18 条
  • [1] Yadav VK(2009)A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure Cell 138 976-989
  • [2] Forbes AP(1991)Fuller Albright: his concept of postmenopausal osteoporosis and what came of it Clin. Orthop. Relat. Res. 269 128-141
  • [3] Ettinger B(1998)Associations between low levels of serum estradiol, bone density, and fractures among elderly women: the study of osteoporotic fractures J. Clin. Endocrinol. Metab. 83 2239-2243
  • [4] Weng MY(2007)Medication-induced osteoporosis Curr. Osteoporos. Rep. 4 139-145
  • [5] Lane NE(2000)Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass Cell 100 197-207
  • [6] Ducy P(2008)Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice Proc. Natl Acad. Sci. USA 105 5266-5270
  • [7] Ferron M(2009)Glucocorticoid-induced osteoporosis Osteoporos. Int. 20 239-240
  • [8] Hinoi E(2009)Serotonin rising—the bone–brain–bowel connection N. Engl. J. Med. 360 957-959
  • [9] Karsenty G(2005)Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth Endocrinology 146 685-693
  • [10] Ducy P(2008)Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum Cell 135 825-837